Form 4: Arteris CFO Sells Shares for Tax Obligations
Insider Transaction Report
Arteris, Inc.'s VP and Chief Financial Officer, Nicholas B. Hawkins, sold 3,887 shares of common stock on October 2, 2025, at $10.9208 per share to cover tax liabilities from restricted stock unit releases.
Summary
- Nicholas B. Hawkins, VP and Chief Financial Officer of Arteris, Inc. (AIP), reported the sale of common stock.
- The transactions occurred on October 2, 2025.
- A total of 3,887 shares were sold across three separate transactions (891, 1,508, and 1,488 shares).
- The shares were sold at a price of $10.9208 per share.
- The purpose of the sales was to satisfy tax liability arising from the release of restricted stock units.
- Following these transactions, Mr. Hawkins directly beneficially owns 100,011 shares of Arteris, Inc. common stock.
- The transactions were made pursuant to a Rule 10b5-1 plan.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction for tax purposes, which is a neutral event. It reflects the vesting of executive compensation but also a reduction in direct insider ownership.
Positives
- The sale was explicitly for tax liability arising from the release of restricted stock units, indicating the vesting of executive compensation.
- The transaction was conducted under a Rule 10b5-1 plan, suggesting a pre-arranged, non-discretionary sale.
Negatives
- An insider sale, even for tax purposes, reduces the executive's direct equity stake in the company.
Future Outlook
Not applicable, as this Form 4 filing reports a past insider transaction and does not contain forward-looking statements or guidance.
Management Comments
- Shares sold to satisfy the Reporting Person's tax liability arising as a result of the release of restricted stock units.
Industry Context
Insider sales for tax purposes following restricted stock unit vesting are a common occurrence across all industries, particularly for executives whose compensation packages include equity awards. These transactions are typically pre-scheduled under Rule 10b5-1 plans to avoid accusations of trading on material non-public information.
Comparison to Industry Standards
- This type of insider transaction, specifically the sale of shares to cover tax obligations upon the vesting of restricted stock units, is a standard practice for executives in publicly traded companies across various sectors. It does not indicate any unusual activity compared to peers in the semiconductor IP or technology industry.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Plan | The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). | 10/02/2025 | Indicates a pre-arranged, non-discretionary sale, reducing the risk of insider trading allegations and demonstrating adherence to corporate governance best practices regarding executive stock transactions. |
Stakeholder Impact
- Shareholders: A minor reduction in direct insider ownership, but the reason (tax liability from RSU vesting) is generally understood and not typically viewed negatively.
- Management: The transaction is a routine part of executive compensation and tax planning.
Key Dates
| Date | Description |
|---|---|
| 10/02/2025 | Transaction date for the sale of common stock. |
| 10/06/2025 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
Recommendation
holdThis Form 4 filing details a routine insider sale by the CFO to cover tax obligations arising from restricted stock unit vesting. Such transactions are common, often pre-scheduled under Rule 10b5-1 plans, and do not typically signal a change in management's outlook or the company's fundamentals. Therefore, it provides no new information that would warrant a change in investment recommendation for Arteris, Inc. The stock should be held based on broader company performance and market conditions, not this specific filing.
Keywords
Arteris, AIP, Form 4, insider transaction, stock sale, Nicholas Hawkins, CFO, tax liability, restricted stock units, RSU, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.